Biotest AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BTTAY research report →
About the company
Operating globally from its headquarters in Dreieich, Germany, Biotest AG is a pharmaceutical company established in 1946. It specializes in the research, development, manufacturing, and commercialization of biological medicines. The company's operations are structured across its Therapy, Plasma & Services, and Other divisions.
- CEO
- Jorg Schuttrumpf
- IPO
- 2022
- Employees
- 2,495
- HQ
- Dreieich, DE
Price Chart
- Market Cap
- $942.12M
- P/E
- 48.26
- P/S
- 2.18
- P/B
- 2.40
- EV/EBITDA
- 17.22
- Div Yield
- 0.00%
- Gross Margin
- 30.82%
- Op Margin
- 13.01%
- Net Margin
- 3.64%
- ROE
- 5.13%
- ROIC
- 4.18%
- Revenue
- $726.20M · 6.08%
- Net Income
- $26.40M · -79.21%
- EPS
- $0.36 · -77.81%
- Op Income
- $94.50M
- FCF YoY
- 189.20%
- 52W High
- $24.27
- 52W Low
- $22.80
- 50D MA
- $24.18
- 200D MA
- $24.24
- Beta
- 0.00
- Avg Volume
- 11
Get TickerSpark's AI analysis on BTTAY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BTTAY coverage
Recent articles, reports, and earnings notes.
No research on BTTAY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BTTAY report →Similar companies
Peers in the same neighborhood.